As indicated above, the Research Advisory Committee will review progress on all programs and projects. This includes both process evaluation and assessment of progress towards achievement of stated objectives. Regular written reports will be required from all programs and projects, and site reviews will be performed wherever required.

In addition, the Board will perform regular reviews to evaluate whether IC Health is achieving its overall mission. Specific operational and financial milestones will be set, and an external review committee will review the Initiative at regular intervals. In addition to evaluating the internal operations of IC Health, these reviews will evaluate whether the activities of the Initiative have led to increased investment in cardiovascular and diabetes research in low- and middle-income countries, increased numbers of trained researchers, and strengthened research institutions. It will also assess whether the activities of IC Health have led to collateral improvements such as improvements in national or regional policies and programs focused on cardiovascular disease and diabetes control.

The financial activities of the Initiative will be reviewed regularly by the Board, with the guidance of the Honorary Treasurer who holds professional accounting qualifications. The accounts of IC Health will be audited annually by approved external auditors.